Paula Gergen

Davis Polk advised the joint book-running managers in connection with an offering by Juniper Networks, Inc. of $400 million aggregate principal amount of its 1.200% senior notes due…

Davis Polk advised the sales agents on the SEC-registered at-the-market offering by RAPT Therapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. RAPT…

Davis Polk advised the representatives of the several underwriters in connection with the $240 million initial public offering of 12,650,000 shares of common stock of Olema Oncology at $19…

Davis Polk advised the joint book-running managers in connection with a $216.2 million public offering of 5,750,000 shares of common stock by NanoString Technologies, Inc., which…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by The Marcus Corporation of $100.05 million aggregate principal amount of its 5…

Davis Polk advised the dealer manager in connection with a cash tender offer by Rackspace Technology Global, Inc., an indirect subsidiary of Rackspace Technology, Inc., for up to $600…

Davis Polk advised the representatives of the several underwriters in connection with the $703.5 million initial public offering of 33,500,000 shares of common stock of Rackspace Technology…

Davis Polk advised the joint book-running managers on an SEC-registered debt offering by Alphabet Inc., consisting of $1 billion of 0.450% notes due 2025, $1 billion of 0.800% notes…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Zscaler, Inc. of $1.15 billion aggregate principal amount of its 0.125%…

Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $850 million aggregate…